Literature DB >> 20581653

Life-threatening asymptomatic incidentaloma: a case report of idiopathic CD4 lymphocytopenia and opportunistic infections.

Ephraim L Tsalik1, Lauren Brett Jaggers.   

Abstract

Incidental lung nodules can be due to a variety of etiologies. Management is guided by the most likely or urgent pathology, which is frequently malignancy in an elderly smoker. We present the case of a 62-year-old, long-time smoker, with an incidental lung nodule. Pursuit of the underlying etiology revealed disseminated cryptococcal and Mycobacterium avium intracellulare infections, which are most often seen in patients with advanced human immunodeficiency virus-acquired immunodeficiency syndrome or other immunocompromise. This patient was ultimately determined to have idiopathic CD4 lymphocytopenia, a rare and poorly understood acquired immunodeficiency syndrome. Furthermore, Cryptococcus neoformans is well known to cause asymptomatic meningitis in immunocompetent individuals but is very rarely asymptomatic in the immunosuppressed, as was the case with this patient.

Entities:  

Mesh:

Year:  2010        PMID: 20581653     DOI: 10.1097/MAJ.0b013e3181e5f118

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  The CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis.

Authors:  Y Ding; P Li; Q He; H Wei; T Wu; D Xia; M Tan; Y Shi; X Su
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-29       Impact factor: 3.267

Review 2.  Disseminated cryptococcosis with varicella-zoster virus coinfection of idiopathic CD4 + T lymphocytopenia: a case report and literature review.

Authors:  Li Fang; Junli Zhang; Fangfang Lv
Journal:  Virol J       Date:  2022-03-05       Impact factor: 4.099

3.  Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases.

Authors:  Dina S Ahmad; Mohammad Esmadi; William C Steinmann
Journal:  Avicenna J Med       Date:  2013-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.